Log in to save to my catalogue

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensivel...

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensivel...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7776012

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensively Drug-resistant Gram-negatives to Ceftazidime/ Avibactam and Aztreonam Combination Therapy

About this item

Full title

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensively Drug-resistant Gram-negatives to Ceftazidime/ Avibactam and Aztreonam Combination Therapy

Publisher

US: Oxford University Press

Journal title

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S5-S6

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

Subjects

Subjects and topics

More information

Alternative Titles

Full title

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensively Drug-resistant Gram-negatives to Ceftazidime/ Avibactam and Aztreonam Combination Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7776012

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7776012

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofaa417.008

How to access this item